Meihua specialises in nanomedicine and biotechonology.
Meihua is a postdoctoral research fellow at the Australian Institute for Bioengineering and Nanotechnology. Her research focuses on developing targeted drug and gene delivery using various nanotechnologies, with a particular emphasis on brain disease theranostics such as glioblastoma and amyotrophic lateral sclerosis.
She has two main research interests:
(1) Developing nanomedicines for penetrating the blood-brain barrier.
(2) Engineering polymerized nanomedicines for gene delivery (e.g., mRNA, antisense oligonucleotides) to human induced pluripotent cells (iPSC).
Meihua is committed to supporting students and early- to mid-career academics. She is an active member of various academic communities, including the Monash University Postgraduate Association, Toastmaster Club, Early-Mid Career Researcher Committee, and the Sun Yat-Sen University Student Union.
Key Publications
- Meihua Luo. Nicolas H. Voelcker, et al. Delivering the promises of gene therapy with nanomedicines in treating central nervous system diseases. Adv. Science. 2022, 9(26), 2201740.
- Meihua Luo†, Yuanchen Li†, Bo Peng, Jacinta White, Ermei Mäkilä, Wing Yin Tong, Chung Hang Jonathan Choi, Bryan Day, Nicolas H. Volecker. A multi-funcitonal porous silicon nanocarrier for glioblastoma treatment. Mol. Pharm. 2022, 20, 1, 545-560.
- Meihua Luo, Guido Lewik, Wing Yin Tong, Nicolas H. Voelcker. Systematic evaluation of transferrin-modified porous silicon nanoparticles for targeted-delivery of doxorubicin to glioblastoma, ACS Appl. Mater. Interfaces 2019, 11 (37), 33637-33649.
- Sana Sheykhzadeh†, Meihua Luo†, Nicolas H. Voelcker, Wing Yin Tong, Transferrin-targeted porous silicon nanoparticles reduce glioblastoma cell migration across tight extracellular space. Sci. Rep. 2020, 10(1). †Equal contribution.
- Youssef Abdalla; Meihua Luo; Ermei Mäkilä; Bryan Day; Nicolas Voelcker; Wing Yin Tong. Effectiveness of porous silicon nanoparticle treatment at inhibiting the migration of a heterogeneous glioma cell population. J. Nanobiotechnology. 2021. 19(1).